Al Hammadi Company for Development and Investment (4007.SE)

Also known as:  Al Hammadi
Data delayed by 15 minutes
29.50 SAR -0.25-0.84%
As of 02 DEC 2020 12:10 GMT|Saudi SE

Al Hammadi Stock Price & Performance Powered By Knowledge Direct

Recommendation
-
Div Yield
-
P/E (Last 12 Month)
28.02
Upside
-
Target Price (Mean)
-
52Wk
16.66 23 MAR
31.75 08 NOV

Open
29.60 SAR
Previous Close
29.50 SAR
Turnover
16.54M SAR
EPS
1.069 SAR
Volume
561,155
Transactions
963
Market Cap
3.54B SAR
IPO Date
14-Jul-2014
Analyst Recommendation
Sell
Hold
Buy
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell

About Al Hammadi Company for Development and InvestmentLast updated on: 31 March 2020

Business Summary
Ownership, operation and management of general hospitals; distribution of medical equipment, medical supplies and pharmaceuticals.
Country of Incorporation
Ownership Type
Established In
1985
Primary Sector
Stock Listing
IDStock TypeCurrencyExchangeSymbol
4007.SSEOrdinarySARSaudi SE4007

Contact details

Primary address
Building: Al Hammadi Hospital - Al Olaya Building
Street: Al Oruba Street
Area: Al Olaya District
P.O. Box: 55004
Country: Saudi Arabia
City: Riyadh
City Suffix: 11534
CONTACT
Region
Riyadh
More
All Health Care News
All Markets News

Ownership

Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing

Executives

HE Mohammed Ibrahim Taher Al Hamadi
Chief Executive Officer and Managing Director
Mr Mohammed Said Suleiman Al Saafeen
Chief Financial Officer
Dr Abdulaziz Saleh Mohammed Hamad Al Hammadi
Chief Operating Officer

Board Members

Mr Saleh Mohammed Hamad Al Hammadi
Chairman
Dr Abdulaziz Mohammed Hamad Al Hammadi
Vice Chairman
Dr Sami Abdullah Dakheilallah Al Said
Director
More

Company information provided by Refinitiv

Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

Peers

StocksLast Price% Change
PHARMACEUTICALS41.200 SAR0.00
MOUWASAT MED SEV129.600 SAR0.31
SAUDI GERMAN HSP35.950 SAR-0.69
SULAIMAN ALHABIB115.000 SAR2.50
DALLAH HEALTH49.450 SAR-1.49
More

Wednesday Outlook: Dollar hovers near 2-1/2 year low; gold prices dip

Wednesday Outlook: Dollar hovers near 2-1/2 year low; gold prices dip

Investors cautiously eyed developments in US fiscal stimulus talks 

More

Most Viewed Stocks

Stock Screener

More